search
Back to results

PROSPECTIVE EVALUATION OF HEARTFOCUS (HF_01)

Primary Purpose

Cardiac Disease

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Prospective evaluation of HeartFocus Device (Software)
Sponsored by
DESKi
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Cardiac Disease focused on measuring Cardiac disease, Novices, Guidance, Artificial intelligence, Ejection Fraction, Ultrasound

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Patient (male or female) over 18 years old, Patient having an echocardiography examination scheduled in one of the two investigation centers. Patient who has given his non-objection to participate in the research Exclusion Criteria: Patient subject to a measure of legal protection (safeguard of justice, guardianship or curatorship), Patient deprived of liberty by judicial or administrative decision, Patient being unable to give his non-objection, Pregnant or breastfeeding women, Patient with cardiac anatomy that does not allow reference electrocardiographic sections to be made (situs inversus, single ventricle, congenital anomalies, etc), Patient having benefited from prior echocardiographic exams whose reports mention poor or weak echogenicity, Patient having known chest deformity that has already been mentioned in previous reports or has been the subject of investigations (pectum excavatum), Patient who has undergone total or partial pneumectomy

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Medical Device (Software)

    Arm Description

    ONLY FOR CLINICAL TRIALS

    Outcomes

    Primary Outcome Measures

    Primary endpoints
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (qualitative yes/no): • The left ventricular size (yes/no)
    Primary endpoints
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (qualitative yes/no): • The left ventricular function (yes/no)
    Primary endpoints
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (qualitative yes/no): • The right ventricle size (yes/no)
    Primary endpoints
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (qualitative yes/no): • The presence of non-trivial pericardial effusion (yes/no)

    Secondary Outcome Measures

    Secondary endpoints - Qualitative
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): • The function of the right ventricle?
    Secondary endpoints - Qualitative
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): • The size of the inferior vena cava?
    Secondary endpoints - Qualitative
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): • The size of the left atrium?
    Secondary endpoints - Qualitative
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): • The aortic valve?
    Secondary endpoints - Qualitative
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): • The mitral valve?
    Secondary endpoints - Qualitative
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): •The tricuspid valve
    Secondary endpoints - Qualitative
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): • The segmental kinetics?
    Secondary endpoints - Qualitative
    2- The cardiologists will evaluate whether the quality of each clip is good enough for their interpretation (qualitative yes/no)?
    Secondary endpoints - Quantitative
    The cardiologists will determine on the ultrasound measurements (quantitative): • Left ventricular
    Secondary endpoints - Quantitative
    The cardiologists will determine on the ultrasound measurements (quantitative): o End-systolic and end-diastolic volumes
    Secondary endpoints - Quantitative
    The cardiologists will determine on the ultrasound measurements (quantitative): o Left ventricular function.
    Secondary endpoints - Quantitative
    The cardiologists will determine on the ultrasound measurements (quantitative): o Left ventricular parameters will be assessed by cardiologists
    Secondary endpoints - Quantitative
    The cardiologists will determine on the ultrasound measurements (quantitative): • Parasternal analysis
    Secondary endpoints - Quantitative
    The cardiologists will determine on the ultrasound measurements (quantitative): o Septal wall thickness
    Secondary endpoints - Quantitative
    The cardiologists will determine on the ultrasound measurements (quantitative): o Posterior wall thickness
    Secondary endpoints - Quantitative
    The cardiologists will determine on the ultrasound measurements (quantitative): o Internal diameter of the left ventricle (systole and diastole)
    Secondary endpoints - Quantitative
    The cardiologists will determine on the ultrasound measurements (quantitative): o Aortic diameter
    Secondary endpoints - Quantitative
    The cardiologists will determine on the ultrasound measurements (quantitative): • Diameter of the inferior vena cava
    Secondary endpoints - Diagnotics
    The cardiologists will determine on the ultrasound exam, is there : (yes/no) a left ventricular hypertrophy? a right ventricular hypertrophy? a dilation of the left ventricle? a dilation of the right ventricle? a dilation of the left atrium? a dilation of the right atrium? an abnormal left ventricular function? an abnormal right ventricular function? an abnormal mitral valve? an abnormal tricuspid valve? an abnormal aortic valve? a pericardial effusion? a dilatation of the inferior vena cava? a kinetic disorder? another abnormality? (comments)

    Full Information

    First Posted
    May 5, 2023
    Last Updated
    May 16, 2023
    Sponsor
    DESKi
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05874128
    Brief Title
    PROSPECTIVE EVALUATION OF HEARTFOCUS
    Acronym
    HF_01
    Official Title
    PROSPECTIVE EVALUATION OF HEARTFOCUS: A SOFTWARE SUPPORTING THE ACQUISITION OF CARDIAC ULTRASOUND EXAMS
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    July 1, 2023 (Anticipated)
    Primary Completion Date
    December 1, 2023 (Anticipated)
    Study Completion Date
    December 1, 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    DESKi

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The study's objective is to evaluate if exams, performed with the HeartFocus software by novices, are of sufficient quality to visually analyze the left ventricular size, the left ventricular function, the right ventricular size, and the presence of non-trivial pericardial effusion. Novices will be nurses without prior ultrasound experience who have received dedicated training on cardiac ultrasound and on Heartfocus software. Ultrasound exams will be limited to the acquisition of 10 reference views
    Detailed Description
    This prospective multicentric international pivotal trial will evaluate the ability of the Heartfocus software to support novices for the acquisition of 10 reference views of cardiac ultrasound. The 10 reference views are the following: Parasternal long axis, Parasternal short axis at the aortic valve, Parasternal short axis at the mitral valve Parasternal short axis at the papillary muscles Apical 5-chamber, Apical 4-chamber, Apical 3-chamber, Apical 2-chamber, Subcostal 4-chamber, Subcostal inferior vena cava. Patients included in the study will be adult patients scheduled for an echocardiogram at one of the two investigating centers. Ultrasound exams will be limited to the acquisition 10 reference views. Patients will receive 2 additional limited exams, which consist of the acquisition of ultrasound clips for each of the 10 references views: one by a novice, nurses having received a dedicated training of 2 days, with an ultrasound probe and the HeartFocus software with the guidance system, one by an expert (experienced sonographer/cardiologist) with the same ultrasound probe and the HeartFocus software without the guidance system. A total of 8 novices will perform the acquisition on 30 patients each. In total 240 patients will be included in the study, half in each investigator center. The exams (240 acquired by novices, 240 by experts) will be analyzed by cardiologists to assess their quality. The endpoints are described below.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cardiac Disease
    Keywords
    Cardiac disease, Novices, Guidance, Artificial intelligence, Ejection Fraction, Ultrasound

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    240 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Medical Device (Software)
    Arm Type
    Experimental
    Arm Description
    ONLY FOR CLINICAL TRIALS
    Intervention Type
    Device
    Intervention Name(s)
    Prospective evaluation of HeartFocus Device (Software)
    Intervention Description
    The primary objective of the study is to evaluate if exams, performed with the HeartFocus software by novices, are of sufficient quality to analyze visually
    Primary Outcome Measure Information:
    Title
    Primary endpoints
    Description
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (qualitative yes/no): • The left ventricular size (yes/no)
    Time Frame
    Through study completion, an average of 8 months
    Title
    Primary endpoints
    Description
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (qualitative yes/no): • The left ventricular function (yes/no)
    Time Frame
    Through study completion, an average of 8 months
    Title
    Primary endpoints
    Description
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (qualitative yes/no): • The right ventricle size (yes/no)
    Time Frame
    Through study completion, an average of 8 months
    Title
    Primary endpoints
    Description
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (qualitative yes/no): • The presence of non-trivial pericardial effusion (yes/no)
    Time Frame
    Through study completion, an average of 8 months
    Secondary Outcome Measure Information:
    Title
    Secondary endpoints - Qualitative
    Description
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): • The function of the right ventricle?
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Qualitative
    Description
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): • The size of the inferior vena cava?
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Qualitative
    Description
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): • The size of the left atrium?
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Qualitative
    Description
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): • The aortic valve?
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Qualitative
    Description
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): • The mitral valve?
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Qualitative
    Description
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): •The tricuspid valve
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Qualitative
    Description
    The cardiologists will evaluate whether the ultrasound exam performed has sufficient quality to visually analyze (yes/no): • The segmental kinetics?
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Qualitative
    Description
    2- The cardiologists will evaluate whether the quality of each clip is good enough for their interpretation (qualitative yes/no)?
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Quantitative
    Description
    The cardiologists will determine on the ultrasound measurements (quantitative): • Left ventricular
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Quantitative
    Description
    The cardiologists will determine on the ultrasound measurements (quantitative): o End-systolic and end-diastolic volumes
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Quantitative
    Description
    The cardiologists will determine on the ultrasound measurements (quantitative): o Left ventricular function.
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Quantitative
    Description
    The cardiologists will determine on the ultrasound measurements (quantitative): o Left ventricular parameters will be assessed by cardiologists
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Quantitative
    Description
    The cardiologists will determine on the ultrasound measurements (quantitative): • Parasternal analysis
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Quantitative
    Description
    The cardiologists will determine on the ultrasound measurements (quantitative): o Septal wall thickness
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Quantitative
    Description
    The cardiologists will determine on the ultrasound measurements (quantitative): o Posterior wall thickness
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Quantitative
    Description
    The cardiologists will determine on the ultrasound measurements (quantitative): o Internal diameter of the left ventricle (systole and diastole)
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Quantitative
    Description
    The cardiologists will determine on the ultrasound measurements (quantitative): o Aortic diameter
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Quantitative
    Description
    The cardiologists will determine on the ultrasound measurements (quantitative): • Diameter of the inferior vena cava
    Time Frame
    Through study completion, an average of 8 months
    Title
    Secondary endpoints - Diagnotics
    Description
    The cardiologists will determine on the ultrasound exam, is there : (yes/no) a left ventricular hypertrophy? a right ventricular hypertrophy? a dilation of the left ventricle? a dilation of the right ventricle? a dilation of the left atrium? a dilation of the right atrium? an abnormal left ventricular function? an abnormal right ventricular function? an abnormal mitral valve? an abnormal tricuspid valve? an abnormal aortic valve? a pericardial effusion? a dilatation of the inferior vena cava? a kinetic disorder? another abnormality? (comments)
    Time Frame
    Through study completion, an average of 8 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Patient (male or female) over 18 years old, Patient having an echocardiography examination scheduled in one of the two investigation centers. Patient who has given his non-objection to participate in the research Exclusion Criteria: Patient subject to a measure of legal protection (safeguard of justice, guardianship or curatorship), Patient deprived of liberty by judicial or administrative decision, Patient being unable to give his non-objection, Pregnant or breastfeeding women, Patient with cardiac anatomy that does not allow reference electrocardiographic sections to be made (situs inversus, single ventricle, congenital anomalies, etc), Patient having benefited from prior echocardiographic exams whose reports mention poor or weak echogenicity, Patient having known chest deformity that has already been mentioned in previous reports or has been the subject of investigations (pectum excavatum), Patient who has undergone total or partial pneumectomy
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Bertrand Moal, MD,PhD
    Phone
    +33663760854
    Email
    bertrand.moal@deski.io
    First Name & Middle Initial & Last Name or Official Title & Degree
    Olivier Moal
    Phone
    +33 6 46 38 50 05
    Email
    olivier.moal@deski.io
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Biana Trost, MD, FACC, FASE
    Organizational Affiliation
    Department of Cardiology Lenox Hill Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    PROSPECTIVE EVALUATION OF HEARTFOCUS

    We'll reach out to this number within 24 hrs